Please login to the form below

Not currently logged in
Email:
Password:

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

She will succeed Jeffrey Chodakewitz

Vertex Pharmaceuticals, a biotech known for its clinical development programmes in cystic fibrosis, has appointed a new chief medical officer in the form of Reshma Kewalramani.

She succeeds Jeffrey Chodakewitz, who will remain at the company as a senior advisor through early 2019.

Jeffrey Leiden, chairman, president and chief executive officer of Vertex, said: “Reshma’s depth of medical knowledge, paired with her experience and proven track record as a clinical leader at Vertex, makes her an ideal successor to Jeff.

“I look forward to working with her to continue to advance our clinical development pipeline in cystic fibrosis and other serious diseases.”

Prior to joining the biotech, Kewalramani served as vice president, head of the US medical organisation at Amgen, where she spent 12 years in various capacities.

She said: “It’s a privilege to work at a company with such a relentless focus on science and deep commitment to improving the lives of patients and their families.

“I am excited to assume the role of CMO and continue our important work to help more people with cystic fibrosis and other serious diseases alongside the talented team at Vertex.”

6th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics